All Episodes

Renal and Hepatic Impairment (Ep. 59)

Beyond Small Molecules—Allometric Scaling for Biologics and Engineered mAbs (Ep. 58)

Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)

Examining Volume of Distribution (Ep. 56)

Talking about data science with Mike Stackhouse (Ep. 55)

Using Accelerator Mass Spectrometry in Clinical Pharmacology

Using AI tools for regulatory intelligence (Ep. 53)

When to use model-informed drug development (Ep. 52)

QSP Modeling with Ahmed Elmokadem (Ep. 51)

CDISC datasets and ACoP 2025 (Ep. 50)

Statistics in Pharmacokinetics (Ep. 49)

Clinical Trial Simulations (Ep. 48)

Using R Shiny for Clinical Pharmacology (Ep. 47)

What is useful about noncompartmental analysis? (Ep. 46)

How to select a base PK model (Ep. 45)

Different estimation methods used in modeling (Ep. 44)

What is consulting life like? (Ep. 43)

Population PK modeling with nlmixr (Ep. 42)

Sample size calculations (Ep. 41)

Collaboration with BioTalk Unzipped (Ep. 40)

Toxicokinetics (Ep. 39)

Steady State (Ep. 38)

Dose Proportionality (Ep. 37)

Covariate Search Methods (Ep. 36)

Stimulatory Indirect Response PK-PD Models (Ep. 35)

Inhibitory Indirect Response PK-PD Models (Ep. 34)

Effect compartment PK-PD models (Ep. 33)

Direct effect PKPD models (Ep. 32)

What should you use to present PK results? (Ep. 31)

How important is terminal rate constant? (Ep. 30)

Parellelization in modeling (Ep. 29)

Residual errors and submission packages (Ep. 28)

Simulations (Ep. 27)

Different work environments (Ep. 26)

Biosimilar products (Ep. 25)

Choosing an absorption model (Ep. 24)

What is Aplos NCA? (Ep. 23)

Big announcement and Hepatic impairment studies (Ep. 22)

Project Optimus (Ep. 21)

Tackling TMDD Models (Ep. 20)

Communication for scientists (Ep. 19)

Cell Therapy and Clinical Pharmacology (Ep. 18)

Allometry in Pediatrics and First in Human Studies (Ep. 17)

Computer System Validation for Pharmacometrics (Ep. 16)

QSP, PBPK, PKPD, PopPK … analysis abbreviation soup! (Ep. 15)

Handling BLQ samples (Ep. 13)

Clinical Drug Interaction Studies (Ep. 14)

PK in patients with impaired renal function (Ep. 12)

Model diagnostics and selection (Ep. 11)

Exposure-Response FDA Guidance (Ep. 10)

Finding a job in Clinical Pharmacology (Ep. 9)

QT Prolongation Guidance ICH E14 (Ep. 8)

Pediatric Extrapolation (Ep. 7)

Bioequivalence Guidances from FDA and EMA (Ep. 6)

Nuances of NCA (Ep. 5)

Population PK FDA guidance (Ep. 4)

Comparing NCA and PK models (Ep. 3)

Food Effect FDA Guidance (Ep 2)

Podcast about clinical pharmacology (Ep 1)